cholestyramine resin has been researched along with cysteamine in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (cysteamine) | Trials (cysteamine) | Recent Studies (post-2010) (cysteamine) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 3,307 | 60 | 666 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frants, RR; Havekes, LM; Hoffer, MJ; Kibirige, MS; Naoumova, RP; Niththyananthan, S; Thompson, GR | 1 |
1 other study(ies) available for cholestyramine resin and cysteamine
| Article | Year |
|---|---|
Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Cysteamine; Dinucleotide Repeats; DNA; Electrophoresis; Exons; Female; Fenofibrate; Genotype; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Immunoblotting; Male; Nuclear Family; Phenotype; Point Mutation; Radiation-Protective Agents; Triglycerides | 1996 |